Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
CD4+ T cells classically recognize antigens that are endocytosedand processed in lysosomes for presentation on major histocompatibilitycomplex (MHC) class II molecules. Here, endogenous Epstein-Barrvirus nuclear antigen 1 (EBNA1) was found to gain access tothis pathway by autophagy. On inhibition of lysosomal acidification,EBNA1, the dominant CD4+ T cell antigen of latent Epstein-Barrvirus infection, slowly accumulated in cytosolic autophagosomes.In addition, inhibition of autophagy decreased recognition byEBNA1-specific CD4+ T cell clones. Thus, lysosomal processingafter autophagy may contribute to MHC class IIrestrictedsurveillance of long-lived endogenous antigens including nuclearproteins relevant to disease.
1 Laboratory of Viral Immunobiology, Rockefeller University, New York, NY 10021, USA. 2 Christopher H. Browne Center for Immunology and Immune Diseases, Rockefeller University, New York, NY 10021, USA. 3 Laboratory of RNA Molecular Biology, Rockefeller University, New York, NY 10021, USA. 4 Pediatrics I, Georg August University of Göttingen, 37099 Göttingen, Germany. 5 Center for Internal Medicine, Hematology, and Oncology, Georg August University of Göttingen, 37099 Göttingen, Germany.
* These authors contributed equally to the presented work.
To whom correspondence should be addressed. E-mail: munzc{at}mail.rockefeller.edu
Interaction of ICP34.5 with Beclin 1 Modulates Herpes Simplex Virus Type 1 Pathogenesis through Control of CD4+ T-Cell Responses.
D. A. Leib, D. E. Alexander, D. Cox, J. Yin, and T. A. Ferguson (2009)
J. Virol.
83, 12164-12171
|Abstract »|Full Text »|PDF »
Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.
J. B. Sacha, J. P. Giraldo-Vela, M. B. Buechler, M. A. Martins, N. J. Maness, C. Chung, L. T. Wallace, E. J. Leon, T. C. Friedrich, N. A. Wilson, et al. (2009)
PNAS
106, 9791-9796
|Abstract »|Full Text »|PDF »
Activation of antibacterial autophagy by NADPH oxidases.
J. Huang, V. Canadien, G. Y. Lam, B. E. Steinberg, M. C. Dinauer, M. A. O. Magalhaes, M. Glogauer, S. Grinstein, and J. H. Brumell (2009)
PNAS
106, 6226-6231
|Abstract »|Full Text »|PDF »
Autophagy Is Essential for Mitochondrial Clearance in Mature T Lymphocytes.
H. H. Pua, J. Guo, M. Komatsu, and Y.-W. He (2009)
J. Immunol.
182, 4046-4055
|Abstract »|Full Text »|PDF »
Autophagy and Its Role in MHC-Mediated Antigen Presentation.
Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation.
D. Li, L. Qian, C. Chen, M. Shi, M. Yu, M. Hu, L. Song, B. Shen, and N. Guo (2009)
J. Immunol.
182, 1799-1809
|Abstract »|Full Text »|PDF »
Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation.
K. Li, K. J. Anderson, Q. Peng, A. Noble, B. Lu, A. P. Kelly, N. Wang, S. H. Sacks, and W. Zhou (2008)
Blood
112, 5084-5094
|Abstract »|Full Text »|PDF »
Efficient Cross-presentation Depends on Autophagy in Tumor Cells.
Y. Li, L.-X. Wang, G. Yang, F. Hao, W. J. Urba, and H.-M. Hu (2008)
Cancer Res.
68, 6889-6895
|Abstract »|Full Text »|PDF »
G. Wan, S. Zhaorigetu, Z. Liu, R. Kaini, Z. Jiang, and C.-a. A. Hu (2008)
J. Biol. Chem.
283, 21540-21549
|Abstract »|Full Text »|PDF »
B Cells Induce Tolerance by Presenting Endogenous Peptide-IgG on MHC Class II Molecules via an IFN-{gamma}-Inducible Lysosomal Thiol Reductase-Dependent Pathway.
Y. Su, G. Carey, M. Maric, and D. W. Scott (2008)
J. Immunol.
181, 1153-1160
|Abstract »|Full Text »|PDF »
Hepatitis C Virus Genotype 1a Growth and Induction of Autophagy.
M. Ait-Goughoulte, T. Kanda, K. Meyer, J. S. Ryerse, R. B. Ray, and R. Ray (2008)
J. Virol.
82, 2241-2249
|Abstract »|Full Text »|PDF »
CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals.
L. Crompton, N. Khan, R. Khanna, L. Nayak, and P. A. H. Moss (2008)
Blood
111, 2053-2061
|Abstract »|Full Text »|PDF »
Gtdap-1 promotes autophagy and is required for planarian remodeling during regeneration and starvation.
C. Gonzalez-Estevez, D. A. Felix, A. A. Aboobaker, and E. Salo (2007)
PNAS
104, 13373-13378
|Abstract »|Full Text »|PDF »
Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?.
J. D. Lunemann, T. Kamradt, R. Martin, and C. Munz (2007)
J. Virol.
81, 6777-6784
|Full Text »|PDF »
Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation.
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing (2007)
J. Virol.
81, 4389-4396
|Full Text »|PDF »
Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction.
B. Heemskerk, T. van Vreeswijk, L. A. Veltrop-Duits, C. C. Sombroek, K. Franken, R. M. Verhoosel, P. S. Hiemstra, D. van Leeuwen, M. E. Ressing, R. E. M. Toes, et al. (2006)
J. Immunol.
177, 8851-8859
|Abstract »|Full Text »|PDF »
Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
C. Sinzger, K. Eberhardt, Y. Cavignac, C. Weinstock, T. Kessler, G. Jahn, and J.-L. Davignon (2006)
J. Gen. Virol.
87, 1853-1862
|Abstract »|Full Text »|PDF »
Association of Antigen-Processing Machinery and HLA Antigen Phenotype of Melanoma Cells with Survival in American Joint Committee on Cancer Stage III and IV Melanoma Patients..
A. Anichini, R. Mortarini, D. Nonaka, A. Molla, C. Vegetti, E. Montaldi, X. Wang, and S. Ferrone (2006)
Cancer Res.
66, 6405-6411
|Abstract »|Full Text »|PDF »
Virus-specific CD4+ T cells: ready for direct attack.
Autophagic programmed cell death by selective catalase degradation.
L. Yu, F. Wan, S. Dutta, S. Welsh, Z. Liu, E. Freundt, E. H. Baehrecke, and M. Lenardo (2006)
PNAS
103, 4952-4957
|Abstract »|Full Text »|PDF »
Molecular Mechanisms and Regulation of Specific and Nonspecific Autophagy Pathways in Yeast.
U. Nair and D. J. Klionsky (2005)
J. Biol. Chem.
280, 41785-41788
|Full Text »|PDF »
Long-Term MHC Class II Presentation of the EBV Lytic Protein BHRF1 by EBV Latently Infected B Cells following Capture of BHRF1 Antigen.
E. Landais, X. Saulquin, M. Bonneville, and E. Houssaint (2005)
J. Immunol.
175, 7939-7946
|Abstract »|Full Text »|PDF »
Optimization of CD4+ T Lymphocyte Response to Human Cytomegalovirus Nuclear IE1 Protein through Modifications of Both Size and Cellular Localization.
S. Delmas, L. Martin, M. Baron, J. A. Nelson, D. N. Streblow, and J.-L. Davignon (2005)
J. Immunol.
175, 6812-6819
|Abstract »|Full Text »|PDF »
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
G. Barba-Spaeth, R. S. Longman, M. L. Albert, and C. M. Rice (2005)
J. Exp. Med.
202, 1179-1184
|Abstract »|Full Text »|PDF »
Autophagy and intracellular surveillance: Modulating MHC class II antigen presentation with stress.
V. L. Crotzer and J. S. Blum (2005)
PNAS
102, 7779-7780
|Full Text »|PDF »
From the Cover: Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.
J. Dengjel, O. Schoor, R. Fischer, M. Reich, M. Kraus, M. Muller, K. Kreymborg, F. Altenberend, J. Brandenburg, H. Kalbacher, et al. (2005)
PNAS
102, 7922-7927
|Abstract »|Full Text »|PDF »